Listen Live

Current Weather

Loading advertisement…

Novo Nordisk’s weight-loss pill boom faces price war test

By Maggie Fick and Stine Jacobsen LONDON/COPENHAGEN, May 5 (Reuters) - Novo Nordisk is seeing brisk early demand for its new weight-loss pill as competition with U.S. rival Eli Lilly intensifies. Investors now want proof that fast-rising prescriptions can offset a bruising price war... Read More.